Characterisation of the Novel HLA ‐ DRB5 *01:02:05 Allele by Next‐Generation Sequencing
HLA · 2025
DOI: 10.1111/tan.70137 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Thibault Pajot und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histocompatibility, Lille University Medical Center, Lille, France. Hauptthemen laut MEDLINE: Alleles, High-Throughput Nucleotide Sequencing, Exons, HLA-DRB5 Chains. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
HLA‐DRB5*01:02:05 differs from the HLA‐DRB5*01:02:01 by one synonymous nucleotide in codon 14 in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histocompatibility, Lille University Medical Center, Lille, France.
- Department of Histocompatibility, Amiens University Medical Center, Amiens, France.
ORCID-Profile: Nicolas Guillaume
Zitieren
APA
Pajot, T., Lion, J., Elsermans, V., Guillaume, N., & Desoutter, J. (2025). Characterisation of the Novel HLA ‐ DRB5 *01:02:05 Allele by Next‐Generation Sequencing. HLA. https://doi.org/10.1111/tan.70137
Vancouver
Pajot T, Lion J, Elsermans V, Guillaume N, Desoutter J. Characterisation of the Novel HLA ‐ DRB5 *01:02:05 Allele by Next‐Generation Sequencing. HLA. 2025. doi:10.1111/tan.70137
BibTeX
@article{Pajot2025,
author = {Pajot, Thibault and Lion, Julien and Elsermans, Vincent and Guillaume, Nicolas and Desoutter, Judith},
title = {Characterisation of the Novel HLA ‐ DRB5 *01:02:05 Allele by Next‐Generation Sequencing},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70137}
}
EUVIMED